Impact of Acute Complications on The Course and Outcome of Severe COVID-19: a Clinical Analysis and Determination of Mortality Predictors
Open Access
- 25 March 2025
- journal article
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (1) , 103-111
Abstract
Aim. To establish the features of the clinical picture, the structure of acute complications and predictors of mortality in patients with a severe course of COVID-19. Materials and methods. 221 patients who were in the intensive care unit (ICU) of City Clinical Hospital No. 1 in Vinnytsia, Ukraine were examined in the period 2020-2023. Among them, 133 (60.2%) patients survived and 88 (39.8%) of patients died as a result of a severe course of COVID-19 (p = 0.02). Results. The mortality rate of patients with a severe course of COVID-19 was 39.8%. Among patients classified as categories 6 and 7 by the WHO, the highest mortality was observed, (p<0.001). In the group of deceased patients, there were significantly more patients with hypertension (73 (83.0%) vs. 90 (67.7%), p=0.008), coronary heart disease (CHD) (83 (94.3%) vs. 91 (68.4%)), p = 0.0001), a combination of CAD and hypertension (72 (81.8%) vs. 79 (59.4%), p < 0.001). In addition, acute/chronic kidney diseases (18 (20.5%) vs. 13 (9.8%), p = 0.022) and cancer were more common (12 (13.6%) vs. 8 (6.0%)), p = 0.046). Among the acute complications that occurred during the stay of patients in the ICU, the deceased patients experienced significantly higher rates of the following conditions: stroke (10 (11.4%) vs. 3 (2.3%), p = 0.006), acute heart failure (9 (10.2%) vs. 4 (3.0%), p = 0.038), pulmonary embolism (9 (10.2%) vs. 3 (2.3%), p = 0.014), infectious toxic shock (10 (11.4%) vs. 1 (0.8%), p = 0.001), acute respiratory distress syndrome (78 (88.6%) vs. 6 (4.5%), p < 0.0001), endstage of renal failure (62 (80.5%) vs. 82 (62.1%), p = 0.006). Additionally, among rhythm disturbances, atrial fibrillation was more prevalent in deceased patients and was associated with a lower survival rate (31 (35.2%) vs. 19 (14.3%), p = 0.0001). Conclusions. The study demonstrated that clinical factors associated with mortality in patients with a severe course of COVID-19 include patient age and с omorbidity such as hypertension, CAD, heart failure and rhythm disorders. Tachyarrhythmias and bradyarrhythmias were more often observed in deceased patients, in particular, they had more frequent AF, which emphasizes its role as a predictor of poor prognosis in patients with COVID-19.Keywords
This publication has 18 references indexed in Scilit:
- The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the FutureThe Journal of Infectious Diseases, 2023
- The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating ItSaudi Journal of Biological Sciences, 2022
- COVID-19 and arrhythmia: An overviewJournal of Cardiology, 2021
- Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case–control studyInternal and Emergency Medicine, 2021
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020
- Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health OutcomesSeminars in Thrombosis and Hemostasis, 2020
- Arrhythmias and COVID-19JACC: Clinical Electrophysiology, 2020
- SARS-CoV-2, COVID-19, and inherited arrhythmia syndromesHeart Rhythm, 2020
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy CasesJAMA Cardiology, 2020
- Coronary artery disease and ventricular tachyarrhythmia: pathophysiology and treatmentCurrent Opinion in Pharmacology, 2013